These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32024834)

  • 1. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig.
    Rubanova Y; Shi R; Harrigan CF; Li R; Wintersinger J; Sahin N; Deshwar AG; ; Morris QD;
    Nat Commun; 2020 Feb; 11(1):731. PubMed ID: 32024834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TrackSigFreq: subclonal reconstructions based on mutation signatures and allele frequencies.
    Harrigan CF; Rubanova Y; Morris Q; Selega A
    Pac Symp Biocomput; 2020; 25():238-249. PubMed ID: 31797600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional mutational signature activities in cancer genomes.
    Timmons C; Morris Q; Harrigan CF
    PLoS Comput Biol; 2022 Dec; 18(12):e1010733. PubMed ID: 36469539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent mutational processes distinguish hypoxic and normoxic tumours.
    Bhandari V; Li CH; Bristow RG; Boutros PC;
    Nat Commun; 2020 Feb; 11(1):737. PubMed ID: 32024819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolutionary history of 2,658 cancers.
    Gerstung M; Jolly C; Leshchiner I; Dentro SC; Gonzalez S; Rosebrock D; Mitchell TJ; Rubanova Y; Anur P; Yu K; Tarabichi M; Deshwar A; Wintersinger J; Kleinheinz K; Vázquez-García I; Haase K; Jerman L; Sengupta S; Macintyre G; Malikic S; Donmez N; Livitz DG; Cmero M; Demeulemeester J; Schumacher S; Fan Y; Yao X; Lee J; Schlesner M; Boutros PC; Bowtell DD; Zhu H; Getz G; Imielinski M; Beroukhim R; Sahinalp SC; Ji Y; Peifer M; Markowetz F; Mustonen V; Yuan K; Wang W; Morris QD; ; Spellman PT; Wedge DC; Van Loo P;
    Nature; 2020 Feb; 578(7793):122-128. PubMed ID: 32025013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A user guide for the online exploration and visualization of PCAWG data.
    Goldman MJ; Zhang J; Fonseca NA; Cortés-Ciriano I; Xiang Q; Craft B; Piñeiro-Yáñez E; O'Connor BD; Bazant W; Barrera E; Muñoz-Pomer A; Petryszak R; Füllgrabe A; Al-Shahrour F; Keays M; Haussler D; Weinstein JN; Huber W; Valencia A; Park PJ; Papatheodorou I; Zhu J; Ferretti V; Vazquez M
    Nat Commun; 2020 Jul; 11(1):3400. PubMed ID: 32636365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-cancer analysis of whole genomes.
    ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
    Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inferring structural variant cancer cell fraction.
    Cmero M; Yuan K; Ong CS; Schröder J; ; Corcoran NM; Papenfuss T; Hovens CM; Markowetz F; Macintyre G;
    Nat Commun; 2020 Feb; 11(1):730. PubMed ID: 32024845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns.
    Jiao W; Atwal G; Polak P; Karlic R; Cuppen E; ; Danyi A; de Ridder J; van Herpen C; Lolkema MP; Steeghs N; Getz G; Morris QD; Stein LD;
    Nat Commun; 2020 Feb; 11(1):728. PubMed ID: 32024849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
    Cortés-Ciriano I; Lee JJ; Xi R; Jain D; Jung YL; Yang L; Gordenin D; Klimczak LJ; Zhang CZ; Pellman DS; ; Park PJ;
    Nat Genet; 2020 Mar; 52(3):331-341. PubMed ID: 32025003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.
    Li X; Kumar S; Harmanci A; Li S; Kitchen RR; Zhang Y; Wali VB; Reddy SM; Woodward WA; Reuben JM; Rozowsky J; Hatzis C; Ueno NT; Krishnamurthy S; Pusztai L; Gerstein M
    Genome Med; 2021 Apr; 13(1):70. PubMed ID: 33902690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CloneSig can jointly infer intra-tumor heterogeneity and mutational signature activity in bulk tumor sequencing data.
    Abécassis J; Reyal F; Vert JP
    Nat Commun; 2021 Sep; 12(1):5352. PubMed ID: 34504064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.
    Bailey MH; Meyerson WU; Dursi LJ; Wang LB; Dong G; Liang WW; Weerasinghe A; Li S; Li Y; Kelso S; ; ; Saksena G; Ellrott K; Wendl MC; Wheeler DA; Getz G; Simpson JT; Gerstein MB; Ding L;
    Nat Commun; 2020 Sep; 11(1):4748. PubMed ID: 32958763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathway and network analysis of more than 2500 whole cancer genomes.
    Reyna MA; Haan D; Paczkowska M; Verbeke LPC; Vazquez M; Kahraman A; Pulido-Tamayo S; Barenboim J; Wadi L; Dhingra P; Shrestha R; Getz G; Lawrence MS; Pedersen JS; Rubin MA; Wheeler DA; Brunak S; Izarzugaza JMG; Khurana E; Marchal K; von Mering C; Sahinalp SC; Valencia A; ; Reimand J; Stuart JM; Raphael BJ;
    Nat Commun; 2020 Feb; 11(1):729. PubMed ID: 32024854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The repertoire of mutational signatures in human cancer.
    Alexandrov LB; Kim J; Haradhvala NJ; Huang MN; Tian Ng AW; Wu Y; Boot A; Covington KR; Gordenin DA; Bergstrom EN; Islam SMA; Lopez-Bigas N; Klimczak LJ; McPherson JR; Morganella S; Sabarinathan R; Wheeler DA; Mustonen V; ; Getz G; Rozen SG; Stratton MR;
    Nature; 2020 Feb; 578(7793):94-101. PubMed ID: 32025018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined burden and functional impact tests for cancer driver discovery using DriverPower.
    Shuai S; ; Gallinger S; Stein LD;
    Nat Commun; 2020 Feb; 11(1):734. PubMed ID: 32024818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoding human cancer with whole genome sequencing: a review of PCAWG Project studies published in February 2020.
    Giunta S
    Cancer Metastasis Rev; 2021 Sep; 40(3):909-924. PubMed ID: 34097189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The repertoire of copy number alteration signatures in human cancer.
    Tao Z; Wang S; Wu C; Wu T; Zhao X; Ning W; Wang G; Wang J; Chen J; Diao K; Chen F; Liu XS
    Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36806386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in oncogenic mutational processes.
    Li CH; Prokopec SD; Sun RX; Yousif F; Schmitz N; ; Boutros PC;
    Nat Commun; 2020 Aug; 11(1):4330. PubMed ID: 32859912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passenger Mutations in More Than 2,500 Cancer Genomes: Overall Molecular Functional Impact and Consequences.
    Kumar S; Warrell J; Li S; McGillivray PD; Meyerson W; Salichos L; Harmanci A; Martinez-Fundichely A; Chan CWY; Nielsen MM; Lochovsky L; Zhang Y; Li X; Lou S; Pedersen JS; Herrmann C; Getz G; Khurana E; Gerstein MB
    Cell; 2020 Mar; 180(5):915-927.e16. PubMed ID: 32084333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.